Celera To Announce Test For Cirrhosis In Hepatitis C Patients
Mon, 01 May 2006 10:00 AM EST
... Maryland-based Celera Genomics on Wednesday was expected to announce a genetic test that it says could predict if a patient with hepatitis C is likely to develop cirrhosis of the liver, the New York Times reports. It is estimated that about 20% of the roughly three million U.S. residents with hepatitis C eventually will develop cirrhosis -- a severe scarring of the liver that can lead to liver failure or liver cancer... click link for more info. ...
Related Topics
- Hepatitis B
- Hepatitis C
- Cirrhosis
- Hepatitis A
- Hepatitis
- Biliary Cirrhosis
- Hepatitis A and Hepatitis B Vaccine
- Hepatitis A Vaccine
- Cirrhosis (Primary Biliary)
- Primary Biliary Cirrhosis
- Hepatitis B Vaccine
- Autoimmune Hepatitis
- Tests
- Diagnostic Tests
- Hemochromatosis
- Viral Load
- Laboratory Tests
- Pregnancy Test
- Vaccinations For HIV/AIDs Patients
- What Your Female Patients Want to Know About Bladder Control

Not Signed In -


